ABSTRACT
Patients with Crohn's disease often require the use of immunosuppressant drugs to control disease activity. Such medication includes steroids, azathioprine, and biologic therapy. These suppress the immune response, and the patient is more susceptible to infection. We present a case of a 69-year-old gentleman with a history of Crohn's colitis who had ongoing symptoms of diarrhoea in spite of standard treatment. Biologic therapy was considered to be the next step, and screening for infection was undertaken prior to use. Three days following anti-TNF treatment, he became drowsy, and examination revealed pyrexia, slurred speech, and nystagmus. Investigation revealed presence of Listeria rhombencephalitis. He demonstrated poor neurological recovery. Listeria monocytogenes is an infection commonly associated with food sources. Some patients develop a self-limiting diarrhoeal illness, but in the immunosuppressed population, the clinical features may be more sinister. Cotrimoxazole prophylaxis is already recommended for those on triple immunosuppression. We propose the early initiation of this treatment, including where biologic use is anticipated. In those on multiple immunosuppressants, a diet similar to that followed in pregnancy may minimise risk of acquiring this infection. Clinicians must always have a high index of suspicion for opportunistic infection in such immunocompromised patients.
ABSTRACT
Cultures of purified hemopoietic stem cells transduced with an activated mutant of M-Ras contained abnormal cells that, despite the presence of only low levels of growth factors, generated large, dense colonies of macrophages and blast cells. Cells from these colonies survived and grew continuously in the absence of growth factors and generated clonal cell-lines that were mainly composed of well-differentiated mast cells, with a low frequency of undifferentiated cells. When transplanted into sublethally irradiated syngeneic mice, four out of four such clones gave rise to a systemic mastocytosis and mast-cell leukemia. However, the donor clones also generated low percentages of cells with the morphological and cell-surface characteristics of erythrocytes, granulocytes, monocytes and T- and B-lymphocytes. These data indicate that signals downstream of activated M-Ras are sufficient to transform hemopoietic stem cells, and while preserving their capacity to generate other cell-lineages in vivo, result in preferential generation of mast cells.
Subject(s)
Cell Differentiation/genetics , Cell Transformation, Neoplastic/genetics , Hematopoietic Stem Cells/pathology , Mast Cells/cytology , Mast Cells/enzymology , Monomeric GTP-Binding Proteins/biosynthesis , Monomeric GTP-Binding Proteins/genetics , ras Proteins/genetics , Animals , Cell Line, Transformed , Cell Transformation, Neoplastic/pathology , Cells, Cultured , Coculture Techniques , Hematopoietic Stem Cells/metabolism , Leukemia, Mast-Cell/enzymology , Leukemia, Mast-Cell/pathology , Mice , Mice, Inbred BALB C , Monomeric GTP-Binding Proteins/physiology , ras Proteins/biosynthesis , ras Proteins/physiologyABSTRACT
The rate of deamidation of the Asn residue in Val-Tyr-Pro-Asn-Gly-Ala (VYPNGA), a model peptide, was determined at pH 9 (400 mM Tris buffer) as a function of temperature and peptide concentration. Over the temperature range 5-65 degrees C, deamidation followed Arrhenius behavior, with an apparent activation energy of 13.3 kcal/mol. Furthermore, increasing the peptide concentration slows the rate of deamidation. Self-stabilization with respect to deamidation has not been reported previously. The rate of deamidation was also determined in the presence of sucrose and poloxamer 407 (Pluronic F127). In both cases, the rate of deamidation was retarded by up to 40% at 35 degrees C. In aqueous solutions containing poloxamer 407, the degree of stabilization is independent of formation of a reversible thermosetting gel. With sucrose, maximum reduction in the deamidation rate was attained with as little as 5% (w/v). Addition of sucrose results in a greater conformational preference for a type II beta-turn structure, which presumably is less prone to intramolecular cyclization and subsequent deamidation.
Subject(s)
Peptides/chemistry , Amides , Asparagine/chemistry , Chromatography, High Pressure Liquid , Circular Dichroism , Excipients/chemistry , Models, Chemical , Poloxamer/chemistry , Protein Conformation , Sucrose/chemistry , Temperature , ThermodynamicsABSTRACT
Photosynthetic gas exchange, nitrogen- and water-use efficiency, leaf water potential and seasonal patterns of leaf production were studied in seven, dominant dry-forest species from the island of Lana'i, Hawaii, including the rapidly colonizing, non-native Schinus terebinthifolius (Raddi). We evaluated whether unique physiological characteristics of the invasive species explain its capacity to rapidly invade dry forests throughout the Hawaiian Islands. Apparent anomalies in stable carbon isotope data (delta13C) relative to other results led us to study effects of environmental conditions and physiological performance during leaf expansion on delta13C. Species that expanded all their foliage at the beginning of the wet season had more negative leaf delta13C values during the dry season than species with continuous leaf expansion. Among species, S. terebinthifolius had a strong seasonal pattern of leaf production and the most negative delta13C (-29 per thousand). With respect to almost every trait measured, S. terebinthifolius fell at an end of the range of values for the native species. Rapid growth of S. terebinthifolius in this ecosystem may be partially explained by its high maximum CO2 assimilation rates (15 micromol m-2 s-1), low leaf mass per area, high photosynthetic nitrogen-use efficiency per unit leaf mass or area and large decrease in stomatal conductance during the dry season. Relative to the native species, the invasive species exhibited striking phenotypic plasticity, including high rates of stem growth and water and CO2 uptake during the wet season, and maintenance of leaves and high leaf water potentials, as a result of reduced water loss, during the dry season, enabling it to utilize available resources effectively.
Subject(s)
Trees/growth & development , Anacardiaceae/growth & development , Anacardiaceae/physiology , Carbon Dioxide/physiology , Hawaii , Nitrogen/physiology , Photosynthesis/physiology , Plant Leaves/physiology , Seasons , Trees/physiologyABSTRACT
OBJECTIVE: To evaluate the effect of the introduction of the Haemophilus influenzae B (Hib) vaccine (introduced first in 1985, then extended in 1990 to children at least 2 months of age) on the epidemiologic features of periorbital and orbital cellulitis. DESIGN: Retrospective, comparative case series. PARTICIPANTS: Three hundred fifteen pediatric inpatients. METHODS: Children at Massachusetts General Hospital and Massachusetts Eye and Ear Infirmary with discharge diagnosis of periorbital or orbital cellulitis from 1980 through 1998 were reviewed. MAIN OUTCOME MEASURES: Case rate, culture-positive isolates, and associated conditions. RESULTS: A total of 297 cases of periorbital cellulitis and 18 cases of orbital cellulitis were reviewed. Before 1990, there were 27 cases of Hib-related cellulitis (11.7% of total in that period), whereas after 1990, there were only three (3.5% of total; P = 0.028). The number of cases per year was significantly lower after 1990 (21.2 +/- 10.4 vs. 8.7 +/- 3.9; P = 0.008), as were the number of positive culture isolates (for any organism) after 1990 (76 [33. 0%] vs. 9 [10.6%]; P < 0.001). The medical conditions most commonly associated with periorbital cellulitis were sinusitis (44 [14.5%]) and upper respiratory infections (73 [26.6%]). All cases of orbital cellulitis were associated with sinusitis. CONCLUSIONS: The introduction of the Hib vaccine coincided with a sharp decline not only in the number of periorbital and orbital cellulitis cases related to H. influenzae, but also in the annual case rate. These data are consistent with a facilitative role for H. influenzae in the development of cellulitis secondary to other pathogens. They also may support restriction of the spectrum of antibiotics used to manage these conditions.
Subject(s)
Cellulitis/prevention & control , Eye Infections, Bacterial/prevention & control , Haemophilus Infections/prevention & control , Haemophilus Vaccines/administration & dosage , Orbital Diseases/prevention & control , Vaccination , Cellulitis/epidemiology , Cellulitis/microbiology , Child , Child, Preschool , Eye Infections, Bacterial/epidemiology , Eye Infections, Bacterial/microbiology , Female , Haemophilus Infections/epidemiology , Haemophilus Infections/microbiology , Haemophilus influenzae/isolation & purification , Humans , Infant , Male , Massachusetts/epidemiology , Orbital Diseases/epidemiology , Orbital Diseases/microbiology , Retrospective Studies , Sinusitis/epidemiology , Sinusitis/microbiology , Sinusitis/prevention & controlABSTRACT
Lowland dry forests are unique in Hawaii for their high diversity of tree species compared with wet forests. We characterized spatial and temporal partitioning of soil water resources among seven indigenous and one invasive dry forest species to determine whether the degree of partitioning was consistent with the relatively high species richness in these forests. Patterns of water utilization were inferred from stable hydrogen isotope ratios (δD) of soil and xylem water, zones of soil water depletion, plant water status, leaf phenology, and spatial patterns of species distribution. Soil water δD values ranged from -20 near the surface to -48 at 130 cm depth. Metrosideros polymorpha, an evergreen species, and Reynoldsia sandwicensis, a drought-deciduous species, had xylem sap δD values of about -52, and appeared to obtain their water largely from deeper soil layers. The remaining six species had xylem δD values ranging from -33 to -42, and apparently obtained water from shallower soil layers. Xylem water δD values were negatively correlated with minimum annual leaf water potential and positively correlated with leaf solute content, an integrated measure of leaf water deficit. Seasonal patterns of leaf production ranged from dry season deciduous at one extreme to evergreen with near constant leaf expansion rates at the other. Species tapping water more actively from deeper soil layers tended to exhibit larger seasonality of leaf production than species relying on shallower soil water sources. Individuals of Myoporum sandwicense were more spatially isolated than would be expected by chance. Even though this species apparently extracted water primarily from shallow soil layers, as indicated by its xylem δD values, its nearly constant growth rates across all seasons may have been the result of a larger volume of soil water available per individual. The two dominant species, Diospyros sandwicensis and Nestegis sandwicensis, exhibited low leaf water potentials during the dry season and apparently drew water mostly from the upper portion of the soil profile, which may have allowed them to exploit light precipitation events more effectively than the more deeply rooted species. Character displacement in spatial and temporal patterns of soil water uptake was consistent with the relatively high diversity of woody species in Hawaiian dry forests.
ABSTRACT
Nationally, the focus on facilities providing effective pain management has increased, yet no funds have been allocated to pain management programs. The article describes a 3-year study whose purpose was to evaluate the effect on nurses' attitudes and behavior of the institution of a multifaceted, low-cost hospital pain management program. The program utilized various instructional methods and implementation of policies, procedures, and documentation protocols. Nurses were surveyed before and after the pain management program using the 39-item Nurses' Knowledge and Attitudes Survey. Results demonstrated a statistically significant increase between pretest and posttest scores.
Subject(s)
Nursing Service, Hospital/standards , Outcome Assessment, Health Care , Pain Management , Pain Measurement/standards , Patient Satisfaction , Program Evaluation , California , Health Knowledge, Attitudes, Practice , Humans , Nursing Service, Hospital/organization & administration , Pain/nursing , Pain Measurement/nursing , Surveys and QuestionnairesABSTRACT
Substitution at the ortho position of N-(3,4-dimethyl-5-isoxazolyl) benzenesulfonamide led to the identification of the biphenylsulfonamides as a novel series of endothelin-A (ETA) selective antagonists. Appropriate substitutions on the pendant phenyl ring led to improved binding as well as functional activity. A hydrophobic group such as isobutyl or isopropoxyl was found to be optimal at the 4'-position. Introduction of an amino group at the 2'-position also led to improved analogues. Combination of the optimal 4'-isobutyl substituent with the 2'-amino function afforded an analogue (20, BMS-187308) with improved ETA binding affinity and functional activity. Compound 20 also has good oral activity in inhibiting the pressor effect caused by an ET-1 infusion in rats. Doses of 10 and 30 micromol/kg iv 20 attenuated the pressor responses due to the administration of exogenous ET-1 to conscious monkeys, indicating that the compound inhibits the in vivo activity of endothelin-1 in nonhuman primates.
Subject(s)
Endothelin Receptor Antagonists , Isoxazoles/chemical synthesis , Sulfonamides/chemical synthesis , Administration, Oral , Animals , Aorta, Thoracic/drug effects , Aorta, Thoracic/physiology , Blood Pressure/drug effects , Carotid Arteries/drug effects , Carotid Arteries/physiology , Cerebellum/drug effects , Cerebellum/metabolism , Endothelin-1/pharmacology , Female , In Vitro Techniques , Injections, Intravenous , Isoxazoles/administration & dosage , Isoxazoles/chemistry , Isoxazoles/pharmacology , Macaca fascicularis , Male , Rabbits , Radioligand Assay , Rats , Receptor, Endothelin A , Structure-Activity Relationship , Sulfonamides/administration & dosage , Sulfonamides/chemistry , Sulfonamides/pharmacology , Vasoconstriction/drug effectsABSTRACT
Sustained delivery systems can achieve more constant blood levels of protein therapeutics than those obtained with bolus doses, leading to improved drug efficacy and fewer adverse side effects. Several different polymeric delivery systems have been studied, including poloxamers, which are unique because they can be prepared in aqueous buffers that are compatible with proteins. Poloxamers are nontoxic block copolymers of poly(ethylene oxide) and poly(propylene oxide). Certain poloxamers exhibit reversible thermal gelation. Thus, a solution of protein and poloxamer prepared at low temperatures and injected extravascularly will form a gel as it warms to body temperature. Subsequently, the protein is released slowly from the gel. To date, however, poloxamer gel delivery systems have been limited to relatively low protein concentrations (i.e., < or = 0.4 mg/mL) that produce a completely soluble protein and an optically clear gel. Much higher concentrations of other protein drugs might be needed to obtain an efficacious sustained dose. In the current in vitro study we found that a poloxamer 407 (22% wt/wt) matrix could be prepared containing tens of milligrams/mililiter of the model proteins alpha-chymotrypsin and lactate dehydrogenase. Under these conditions the protein forms a homogeneous suspension. Warming through the poloxamer 407 transition temperature (ca. 18 degrees C) results in a gel that retains a homogeneous distribution of protein precipitates for several days at 37 degrees C. Infrared spectroscopy documented that the precipitated proteins in the suspension have native secondary structure. Furthermore, the fully active protein can be recovered completely when the gel is dissolved in excess buffer. Finally, at the higher protein concentrations used to form the suspensions in poloxamer 407, protein stability during incubation at 37 degrees C was greatly improved over that seen at lower protein concentrations.
Subject(s)
Drug Delivery Systems , Poloxalene , Proteins/chemistry , Buffers , Chymotrypsin/chemistry , Drug Stability , L-Lactate Dehydrogenase/chemistry , Solubility , Spectrophotometry, Infrared , TemperatureABSTRACT
A series of 7,6- and 7,5-fused bicyclic thiazepinones and oxazepinones were generated and incorporated as conformationally restricted dipeptide surrogates in mercaptoacyl dipeptides. These compounds are potent inhibitors of angiotensin-converting enzyme (ACE) and neutral endopeptidase (NEP) both in vitro and in vivo. Compound 1a, a 7,6-fused bicyclic thiazepinone, demonstrated excellent blood pressure lowering in a variety of animal models characterized by various levels of plasma renin activity and significantly potentiated urinary sodium, ANP, and cGMP excretion in a cynomolgus monkey assay. On the basis of its potency and duration of action, compound 1a (BMS-186716) was advanced into clinical development for the treatment of hypertension and congestive heart failure.
Subject(s)
Angiotensin-Converting Enzyme Inhibitors/chemical synthesis , Cardiovascular Agents/chemical synthesis , Enzyme Inhibitors/chemical synthesis , Neprilysin/antagonists & inhibitors , Pyridines/chemical synthesis , Thiazepines/chemical synthesis , Animals , Antihypertensive Agents/chemical synthesis , Antihypertensive Agents/therapeutic use , Atrial Natriuretic Factor/urine , Cardiovascular Agents/therapeutic use , Cyclic GMP/urine , Heart Failure/drug therapy , Hypertension/drug therapy , Macaca fascicularis , Pyridines/therapeutic use , Rats , Renin/blood , Sodium/urine , Thiazepines/therapeutic useABSTRACT
This article describes a simple, effective process that provides facilitated variance tracking while meeting the Joint Commission on Accreditation of Healthcare Organizations' requirement for Multidisciplinary Care Plans.
Subject(s)
Critical Pathways/organization & administration , Patient Care Team/organization & administration , Quality Assurance, Health Care/organization & administration , HumansABSTRACT
A novel nucleoside analog BMS-181165 with potent activity against varicella-zoster virus was tested for efficacy in a simian varicella virus infection in African green monkeys. BMS-181165 was effective in preventing the development of a rash, decreasing the development of viremia and preventing death in infected monkeys when administered orally at 4, 16 or 64 mg/kg/day. The compound is well orally absorbed in monkeys, between 44 to 50% oral bioavailability, and may prove of value in therapy of varicella-zoster infections in humans.
Subject(s)
Antiviral Agents/pharmacokinetics , Herpesviridae Infections/prevention & control , Herpesvirus 1, Cercopithecine , Uridine/analogs & derivatives , Administration, Oral , Animals , Antiviral Agents/administration & dosage , Antiviral Agents/blood , Biological Availability , Chlorocebus aethiops , Disease Models, Animal , Herpesviridae Infections/complications , Treatment Outcome , Uridine/administration & dosage , Uridine/blood , Uridine/pharmacokinetics , Viremia/prevention & controlABSTRACT
A range of thromboxane A2 receptor blocking (TxRB) drugs, prostacyclin and aspirin have been assessed as inhibitors of human platelet deposition onto rabbit and human de-endothelialized arteries in vitro. Platelet deposition was quantified by measuring the radioactivity associated with de-endothelialized arteries following superfusion with 111indium-labelled human platelets reconstituted in blood. Using rabbit aorta, all of the compounds tested produced a similar maximum inhibition (approximately 70%) of platelet deposition; from scanning EM studies the residual deposition appeared to represent a monolayer of adhered platelets. The potency of the TxRB's for inhibiting deposition was GR32191 greater than or equal to GR36246 greater than SQ29,548 greater than ICI185282 greater than or equal to AH23848 much greater than BM13.177 consistent with their TxRB potency on human platelets. Using human umbilical arteries, the TxRB's achieved a smaller maximum inhibition of deposition (approximately 50%) than did prostacyclin or the fibrinogen receptor blocking peptide Gly-Arg-Gly-Asp-Ser (GRGDS) (60-75%). In addition, using human umbilical arteries, the structurally-related TxRB's GR32191 and GR36246 exhibited a greater than 1000-fold enhancement in potency as inhibitors of platelet deposition over that seen in the rabbit aorta. In preliminary experiments, GR32191 also displayed a similar high potency on human cerebral arteries. In contrast, the structurally unrelated compounds SQ29,548, ICI185282 and BM13.177 exhibited similar potencies on human umbilical arteries to those observed on the rabbit aorta; aspirin and prostacyclin also displayed similar potencies on the two preparations. The enhanced effect of GR32191 and GR36246 on human umbilical arteries therefore appears unrelated to their action as TxRB's on human platelets although the mechanism of this unique action is at present unknown. However, if these drugs exhibited a similar high potency for preventing mural thrombus formation in vivo in man, they may represent a major advance in the treatment of occlusive vascular disease.
Subject(s)
Biphenyl Compounds/pharmacology , Heptanoic Acids/pharmacology , Platelet Aggregation Inhibitors/pharmacology , Receptors, Prostaglandin/antagonists & inhibitors , Animals , Aorta/metabolism , Arteries/drug effects , Endothelium, Vascular/physiology , Epoprostenol/biosynthesis , Humans , Indium Radioisotopes , Microscopy, Electron , Microscopy, Electron, Scanning , Molecular Structure , Rabbits , Receptors, Thromboxane , Umbilical Arteries/metabolismABSTRACT
GR32191, a potent selective thromboxane receptor antagonist, has been shown to inhibit completely prostaglandin endoperoxide and thromboxane A2 (TxA2)-induced platelet aggregation, [14C]-serotonin secretion and beta-thromboglobulin secretion. Deposition of human platelets onto damaged rabbit aorta in vitro is reduced in the presence of GR32191 which appears to inhibit aggregation of platelets but not direct adhesion of platelets to subendothelium. The effects of non-prostanoid platelet activating agents whose mode of action requires the biosynthesis of TxA2 are also inhibited by GR32191. Prostanoids which inhibit platelet function, such as prostacyclin or PGD2, retain their inhibitory properties in the presence of GR32191 which does not inhibit phospholipase A2, prostaglandin cyclooxygenase, thromboxane synthase, 12-lipoxygenase or cAMP phosphodiesterase activity. The inhibitory action of GR32191 on platelet aggregation, mural thrombus formation and platelet protein storage granule secretion suggests that it has potential in treating thrombotic disease in man.
Subject(s)
Biphenyl Compounds/pharmacology , Blood Platelets/metabolism , Heptanoic Acids/pharmacology , Platelet Adhesiveness/drug effects , Platelet Aggregation Inhibitors/pharmacology , Platelet Aggregation/drug effects , Blood Platelets/drug effects , Blood Platelets/enzymology , Enzyme Inhibitors/pharmacology , Humans , Receptors, Prostaglandin , Receptors, Thromboxane , Serotonin/blood , Thromboxane B2/biosynthesis , Thromboxane B2/metabolism , beta-Thromboglobulin/metabolismABSTRACT
Liposome encapsulated hemoglobin has numerous advantages as a red cell substitute. LEH has no blood type and can be made virus-free and sterile in large quantities. The technology is compatible with the use of either human or bovine hemoglobin and does not require chemical modification of the hemoglobin. Cofactors can be included in the liposome to modify the P50 and to prevent methemoglobin formation. The inclusion of dissacharides stabilizes the LEH during freezing and dehydration and provides a method for long-term storage. Most importantly, LEH can sustain life in animals after removal of red cells to lethal levels for periods commensurate with a 16-20 hour circulation half-life.
Subject(s)
Blood Substitutes/administration & dosage , Hemoglobins/administration & dosage , Animals , Antioxidants/pharmacology , Blood Pressure/drug effects , Cattle , Drug Carriers , Drug Stability , Drug Storage , Excipients/pharmacology , Freeze Drying , Hematocrit , Humans , Liposomes , Methemoglobin/metabolism , Rats , Rats, Inbred StrainsABSTRACT
A 38-year-old woman with chronic, noncyclic neutropenia had an episode of acute abdominal pain associated with clostridial septicemia. Clostridium paraputrificum was isolated from blood and peritoneal cultures. The pathogenic potential of C paraputrificum was established by surgical biopsy specimens which demonstrated necrotizing enterocolitis with the typical gram-positive rods. This report strengthens a recognized, established association between neutropenia and clostridial infection.
Subject(s)
Clostridium Infections , Enterocolitis, Pseudomembranous/complications , Sepsis/complications , Adult , Clostridium Infections/diagnosis , Clostridium Infections/therapy , Enterocolitis, Pseudomembranous/diagnosis , Enterocolitis, Pseudomembranous/therapy , Female , Humans , Neutropenia/complications , Sepsis/diagnosis , Sepsis/therapyABSTRACT
Preventing the oxidation of hemoglobin in solution is one of the major requirements for the successful production and long-term storage of hemoglobin-based blood substitutes. To this end we have studied the effects of antioxidants on the rate of methemoglobin formation and disappearance in solutions of human and bovine hemoglobin at 4 degrees C and 37 degrees C. Ascorbate and desferal (5 mM) were observed to act as prooxidants, increasing the rate of methemoglobin formation at 37 degrees C. Trehalose, mannitol, glucose, and EDTA (5 mM) had no significant effect. Glutathione and NADH (10 mM) were the most effective antioxidants tested, causing a significant decrease in the rate of methemoglobin formation at 37 degrees C for periods of up to 50 hours. The combination of these antioxidants in bovine hemoglobin at 4 degrees C resulted in the reduction of methemoglobin levels to nearly undetectable levels in approximately 150 hours. In addition, NADH and glutathione were found to reduce methemoglobin levels to 10% over a period of 100 hours in a sample of human hemoglobin that had been stored at 4 degrees C for one year and had 60% methemoglobin. These results suggest that the prevention and reversal of methemoglobin formation during the long-term storage of hemoglobin solutions and hemoglobin-based blood substitutes may now be possible.
Subject(s)
Antioxidants/pharmacology , Methemoglobin/metabolism , Animals , Cattle , Humans , In Vitro Techniques , Oxidation-ReductionABSTRACT
A rapid and sensitive method for the quantitative determination of folylpolyglutamate hydrolase activity in crude tissue extracts was developed. The procedure is based on high-performance liquid chromatographic separation of folate analogue mono- and polyglutamates on a reversed-phase column using sodium dodecyl sulfate in water as the mobile phase. Interfering substances in tissue extracts were removed by gel filtration on centrifugally-eluted mini-columns of Sephadex G-25 prior to incubation of polyglutamate substrate with tissue extract hydrolase. Reactions were terminated by denaturation of the enzyme in sodium dodecyl sulfate, which subsequently served as the micellar solvent system for chromatographic separation of substrate from reaction products.